Drugmaker Novartis plans to spend $23 billion at 10 of its U.S. facilities, as the pharma industry grapples with Trump’s ...

Novartis expects the new capacity will allow it to produce all of its key medicines “end to end” in the U.S., as the Trump ...

The pharmaceutical industry is on the brink of massive transformation driven by cutting-edge technology and strategic ...

Exiger warns the U.S. is overly reliant on foreign countries to make key components of crucial medications as the Trump ...

Experts say the tariffs are unlikely to bring back production of generic medicines, given their slim profit margins ...

Piramal Pharma Limited (PPL) is a leading pharmaceutical company and part of the Piramal Group. The company was established ...

Divi's Laboratories climbed 3.50% to Rs 5835.95 after the company said it inked a long-term manufacturing and supply agreement with a leading global pharmaceutical company.

Still, some major US pharmaceutical companies have made large investments in domestic manufacturing recently ... with the ...

Divi's Labs said it will invest Rs 650-700 crore in capacity expansion and that it eyes significant revenue boost ...

Donald Trump announced a forthcoming "major" tariff on pharmaceutical imports, aiming to incentivize drug companies to ...